Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci and other bacteria : protective effect of antioxidants
Author: Bouhafs, Rabea K L
Date: 2002-09-27
Location: Birkeaulan 1, Huddinge Universitetssjukhus, F-huset, plan 5
Time: 9.00
Department: Institutionen för immunologi, mikrobiologi, patologi och infektionssjukdomar / Department of Immunology, Microbiology, Pathology and Infectious Diseases
Abstract
Respiratory distress syndrome (RDS), caused by surfactant deficiency, is a leading cause of mortality and morbidity in preterm neonates. Further, infants with systemic neonatal infection or pneumonia often have signs of RDS. As neonatal infection and RDS may occur simultaneously, infants with infections may receive exogenous surfactant as treatment. Our hypothesis was that surfactant lipids are peroxidized by reactive oxygen species from phagocytes and bacteria and that Curosurf, a surfactant preparation given to newborn infants, may be improved by the addition of antioxidants to counteract toxic free radicals.
We studied superoxide production by bacteria and human neutrophils (PMN) by the nitroblue tetrazolium (NBT) test. Also, the nitric oxide (NO) production by rat alveolar macrophages (AM) was measured by Griess reaction. The lipid peroxidation (LPO) of surfactant (Curosurf) was determined as the level of malondialdehyde and 4-hydroxyalkenals. The impact of free radicals on surfactant function was estimated by measuring surface tension. The ability of different antioxidants in counteracting the LPO of surfactant was estimated in vitro. In vivo, we tested the effect of GBS infection and exogenous surfactant treatment in tracheotomized, ventilated, near-term newborn rabbits. Also, the effect of vitamin E as antioxidant was investigated.
Surfactant decreased the superoxide production by bacteria and PMN, as well as the NO production by AM. Surfactant was peroxidized when incubated with resting or with stimulated PMN or AM, but also with bacteria alone, and the LPO increased with time. Vitamin E supplementation decreased the LPO levels. Lung surfactant was bactericidal to group B streptococci (GBS) and Escherichia coli, but Pseudomonas aeruginosa was resistant. The biophysical activity of Curosurf was impaired by GBS-stimulated PMN, as reflected by an increased surface tension. All antioxidants (SOD, vitamin E, vitamin C, ebselen and melatonin) tested except vitamin C decreased superoxide production and surfactant peroxidation by PMN in a dose dependent manner. The best combination was that of a natural and a synthetic antioxidant (melatonin-ebselen). In the in vivo model we found that GBS infected rabbits had higher LPO of their lung lavage fluid than uninfected animals. The LPO level could be diminished by adding vitamin E to exogenous surfactant.
Our findings suggest that antioxidants supplementation can improve the surfactant therapy when given to infants with GBS pneumonia.
We studied superoxide production by bacteria and human neutrophils (PMN) by the nitroblue tetrazolium (NBT) test. Also, the nitric oxide (NO) production by rat alveolar macrophages (AM) was measured by Griess reaction. The lipid peroxidation (LPO) of surfactant (Curosurf) was determined as the level of malondialdehyde and 4-hydroxyalkenals. The impact of free radicals on surfactant function was estimated by measuring surface tension. The ability of different antioxidants in counteracting the LPO of surfactant was estimated in vitro. In vivo, we tested the effect of GBS infection and exogenous surfactant treatment in tracheotomized, ventilated, near-term newborn rabbits. Also, the effect of vitamin E as antioxidant was investigated.
Surfactant decreased the superoxide production by bacteria and PMN, as well as the NO production by AM. Surfactant was peroxidized when incubated with resting or with stimulated PMN or AM, but also with bacteria alone, and the LPO increased with time. Vitamin E supplementation decreased the LPO levels. Lung surfactant was bactericidal to group B streptococci (GBS) and Escherichia coli, but Pseudomonas aeruginosa was resistant. The biophysical activity of Curosurf was impaired by GBS-stimulated PMN, as reflected by an increased surface tension. All antioxidants (SOD, vitamin E, vitamin C, ebselen and melatonin) tested except vitamin C decreased superoxide production and surfactant peroxidation by PMN in a dose dependent manner. The best combination was that of a natural and a synthetic antioxidant (melatonin-ebselen). In the in vivo model we found that GBS infected rabbits had higher LPO of their lung lavage fluid than uninfected animals. The LPO level could be diminished by adding vitamin E to exogenous surfactant.
Our findings suggest that antioxidants supplementation can improve the surfactant therapy when given to infants with GBS pneumonia.
List of papers:
I. Bouhafs RK, Jarstrand C (1999). Phagocyte-induced lipid peroxidation of lung surfactant. Pediatr Pulmonol. 27(5): 322-7.
Pubmed
II. Bouhafs RK, Jarstrand C (1999). Lipid peroxidation of lung surfactant by bacteria. Lung. 177(2): 101-10.
Pubmed
III. Bouhafs RK, Jarstrand C (2000). Interaction between lung surfactant and nitric oxide production by alveolar macrophages stimulated by group B streptococci. Pediatr Pulmonol. 30(2): 106-13.
Pubmed
IV. Bouhafs RK, Rauprich P, Herting E, Schroder A, Robertson B, Jarstrand C (2000). Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci. Lung. 178(5): 317-29.
Pubmed
V. Bouhafs RK, Jarstrand C (2002). Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes. Free Radic Res. 36(7): 727-34.
Pubmed
VI. Bouhafs RKL, Jarstrand C, Robertson B (2002). Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia. [Submitted]
I. Bouhafs RK, Jarstrand C (1999). Phagocyte-induced lipid peroxidation of lung surfactant. Pediatr Pulmonol. 27(5): 322-7.
Pubmed
II. Bouhafs RK, Jarstrand C (1999). Lipid peroxidation of lung surfactant by bacteria. Lung. 177(2): 101-10.
Pubmed
III. Bouhafs RK, Jarstrand C (2000). Interaction between lung surfactant and nitric oxide production by alveolar macrophages stimulated by group B streptococci. Pediatr Pulmonol. 30(2): 106-13.
Pubmed
IV. Bouhafs RK, Rauprich P, Herting E, Schroder A, Robertson B, Jarstrand C (2000). Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci. Lung. 178(5): 317-29.
Pubmed
V. Bouhafs RK, Jarstrand C (2002). Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes. Free Radic Res. 36(7): 727-34.
Pubmed
VI. Bouhafs RKL, Jarstrand C, Robertson B (2002). Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia. [Submitted]
Issue date: 2002-09-06
Publication year: 2002
ISBN: 91-7349-308-2
Statistics
Total Visits
Views | |
---|---|
Direct ...(legacy) | 178 |
Direct ... | 111 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Direct ... | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
Top country views
Views | |
---|---|
United States | 50 |
Sweden | 43 |
China | 42 |
Germany | 39 |
South Korea | 14 |
Ireland | 7 |
Finland | 6 |
Denmark | 3 |
Hong Kong | 3 |
Vietnam | 3 |
Top cities views
Views | |
---|---|
Kiez | 15 |
Seoul | 11 |
Sunnyvale | 8 |
Dublin | 7 |
Beijing | 6 |
Des Moines | 6 |
Shenzhen | 4 |
Ashburn | 3 |
Ballerup | 3 |
Easton | 3 |